Best hospitals in the United States for Parkinson's disease: An evidence-based care comparison

“Best hospitals in the United States for Parkinson's disease” is a question that requires more than a single national ranking. The strongest candidates combine movement-disorder expertise, multidisciplinary treatment, research participation, and long-term support, while the most suitable choice still depends on diagnosis, symptoms, treatment needs, geography, and eligibility for specialized services. 1

How leading Parkinson’s hospitals are identified

Parkinson’s disease care is commonly provided through neurologists with additional fellowship training in movement disorders. The Parkinson’s directory identifies 36 verified centers and practices across the United States, including neurologists, movement-disorder specialists, and Parkinson’s disease centers. Its guidance states that specialist care is associated with fewer hospitalizations and more appropriate medication management, particularly after diagnosis, when medication complications arise, or when a second opinion is being considered. 1

Hospital rankings provide a broader institutional comparison, but they are not identical to a Parkinson’s-specific quality measure. Newsweek’s 2026 neurological-care evaluation considers clinical performance, patient outcomes, and expert input, and lists Parkinson’s disease among the standout specialties assessed. That distinction matters because a hospital may rank highly for neurology overall while patients still need to verify the availability of a dedicated movement-disorder team. 2

Hospitals appearing highest in neurological-care rankings

Newsweek’s 2026 U.S. neurological-care list places Mayo Clinic in Rochester first, Massachusetts General Hospital second, NYU Langone Hospital Tisch Hospital third, UCSF Medical Center fourth, and Johns Hopkins Hospital fifth. Ronald Reagan UCLA Medical Center also appears among the listed institutions. These hospitals are identified as having Parkinson’s disease among their neurological-care specialties, although the ranking covers several neurological conditions rather than Parkinson’s alone. 2

Major centers with research and advanced-care capacity

Mayo Clinic’s Parkinson’s services include an Early-Onset Parkinson’s Disease Clinic for people whose symptoms begin before age 55. The clinic describes a team-based approach focused on diagnosis and treatment for midlife patients, whose symptoms may affect movement, cognition, mood, employment, and family responsibilities. Services are available through Mayo locations in Arizona or Minnesota, with availability varying by location. 3

UCSF operates a Movement Disorder and Neuromodulation Center, while Johns Hopkins maintains a Movement Disorders Center. NYU Langone’s Marlene and Paolo Fresco Institute for Parkinson’s and Movement Disorders is described as providing specialized support and clinical trials. Massachusetts General Hospital’s movement-disorders division is associated with genetic research and personalized medicine. Together, these examples illustrate how clinical care may intersect with research and treatment innovation. 4

Additional nationally recognized neurological programs

Newsweek’s 2026 global neurology ranking places several other U.S. hospitals among the world’s leading specialized institutions. The list includes Cleveland Clinic at fifth, NewYork-Presbyterian Hospital at tenth, Mayo Clinic Hospital in Phoenix at twelfth, Hospital of the University of Pennsylvania at seventeenth, Mount Sinai Hospital at eighteenth, NYU Langone Tisch Hospital at nineteenth, Brigham and Women’s Hospital at twentieth, Stanford Hospital at twenty-first, and Ronald Reagan UCLA Medical Center at twenty-second. 5

These rankings can help identify institutions with broad neurological capacity, but they do not establish that every patient will receive the same Parkinson’s services at every location. A practical assessment should examine whether the site has movement-disorder specialists, coordinated nursing and rehabilitation support, access to clinical trials, and experience with advanced therapies. Those details are more directly relevant to an individual care plan than a hospital’s overall position alone. 5

Parkinson’s Foundation and multidisciplinary designations

Parkinson’s Foundation Centers of Excellence are defined by specialized, multidisciplinary, evidence-based, and patient-centered care, along with professional training, research, patient education, and community outreach. In December 2025, Ohio State University Wexner Medical Center’s Center for Parkinson’s Disease and Other Movement Disorders and Froedtert Hospital in Milwaukee were promoted to Centers of Excellence, joining more than 50 designated centers nationwide. 6

Several institutions in the research data describe this model directly. UF Health reports that it has been a Parkinson’s Foundation Center of Excellence and continuing-care, research, and outreach center for more than 20 years. Jefferson Health also identifies its Parkinson’s program as a Parkinson’s Foundation Center of Excellence, with neurologists, neurosurgeons, and neuropsychologists involved in treatment and clinical trials. 7

Specialized programs beyond the largest rankings

Penn Medicine describes more than four decades of movement-disorders care and a collaborative team involving neurologists, neuropsychologists, neurosurgeons, nurses, nurse practitioners, and social workers. Its program addresses Parkinson’s disease, tremor, and other movement disorders, with ongoing monitoring and customized treatments grounded in research. This type of continuity is important because Parkinson’s management changes as symptoms and treatment responses evolve. 8

Montefiore Einstein’s Comprehensive Movement Disorders Center reports expertise in Parkinson’s disease, essential tremor, dystonia, Tourette syndrome, spasticity, and related conditions. Its services include diagnostic neuroimaging, neurophysiology, genetic and epigenetic technologies, and advanced treatment modalities. The center also describes deep brain stimulation as an option in selected cases, requiring neurosurgical electrode placement followed by programming and refinement of stimulation settings. 9

Research, eligibility, and practical limitations

The NINDS Morris K. Udall Centers of Excellence program supports interdisciplinary Parkinson’s research on disease-associated genes, biological mechanisms, improved disease models, potential therapeutics, and clinical research. Research participation may therefore be an important differentiator for people seeking clinical trials or specialist evaluation, but enrollment is not automatic. Eligibility can depend on the study, diagnosis, symptoms, prior treatments, location, and other protocol requirements. 10

Advanced treatment also involves practical constraints. Deep brain stimulation and focused ultrasound may help selected patients with symptom control, but institutional descriptions show that these approaches require specialist assessment and, for DBS, continuing programming and refinement. Travel, appointment availability, insurance arrangements, referral requirements, and the need for long-term follow-up can create friction. A highly ranked hospital is not necessarily the most appropriate or accessible option for every person. 11

How patients can compare hospitals responsibly

A responsible comparison begins by separating general neurological reputation from Parkinson’s-specific capability. Candidates can be evaluated for verified movement-disorder specialists, multidisciplinary staffing, early-onset expertise when relevant, clinical-trial activity, advanced-treatment experience, rehabilitation coordination, and continuing care. The Parkinson’s specialist directory provides location-based information for verified centers, while institutional programs describe their own clinical scope and team structures. 1

Parkinson’s disease affects movement as well as cognition, mood, walking, balance, and other aspects of health. UF Health estimates that about 90,000 people in the United States receive a diagnosis each year and that approximately 1.1 million Americans are living with the disease, with the number projected to reach 1.2 million by 2030. These figures reinforce the importance of expanding specialist access rather than treating a short ranking as a complete national care map. 12

Sources

1. Parkinsons.org, Find a Parkinson’s Specialist
2. Newsweek, America’s Best Hospitals for Specialized Care 2026, Neurological Care
3. Mayo Clinic, Young-Onset Parkinson’s Disease Clinic
4. UCSF Health, Parkinson’s and Movement Disorders programs; Johns Hopkins Medicine; NYU Langone; Massachusetts General Hospital
5. Newsweek, World’s Best Specialized Hospitals 2026, Neurology
6. Parkinson’s Foundation announcement via PR Newswire, Centers of Excellence
7. UF Health and Jefferson Health, Parkinson’s disease programs
8. Penn Medicine, Movement Disorders Care
9. Montefiore Einstein, Comprehensive Movement Disorders Center
10. National Institute of Neurological Disorders and Stroke, Parkinson’s Disease Research Centers of Excellence
11. Jefferson Health, Parkinson’s disease treatment information
12. UF Health, Parkinson’s disease statistics and institutional information